Advance Auto Parts, Inc. vs Adaptive Biotechnologies Corp — how do they compare? Advance Auto Parts, Inc. trades at $53.31 (market cap $3.19B), while Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B). The key difference: Adaptive Biotechnologies Corp is the larger of the two by market cap, and Advance Auto Parts, Inc. pays a 1.89% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| AAP | ADPT | |
|---|---|---|
Market Cap | $3.19B | $4.04B |
Sector | Consumer Cyclical | Health |
52-Week High | $64.17 | $25.45 |
52-Week Low | $38.75 | $12.30 |
Enterprise Value | $5.47B | $4.10B |
Dividend Yield | 1.89% | — |
Trailing returns across standard periods
Advance Auto Parts is one of the industry's largest retailers of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in North America. Advance operated 4,972 stores as of the end of 2021, in addition to servicing 1,317 independently owned Carquest stores. The company's Worldpac unit is a premier distributor of imported original-equipment parts. Advance derived 58% of its 2021 sales from commercial clients, up from 30%-40% before the General Parts deal.
Read more on AAP →Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →